Effect of extracorporeal membrane oxygenation combined with hemoperfusion on inflammatory factors in patients with cardiogenic shock

Table 1 Baseline characteristics, n (%)

	ECMO (n = 42)	ECMO+HP (n = 39)	P value
Age, year	56.6 ± 14.3	59.2 ± 12.0	0.231
Male	34 (81.0)	24 (61.5)	0.091
Body mass index, kg/m²	25.7 ± 3.3	24.8 ± 2.6	0.102
Etiology of cardiogenic shock
Acute myocardial infarction	30 (71.4)	27 (69.2)	0.807
Myocarditis	2 (4.8)	1 (2.6)
Postcardiac surgery	10 (23.8)	11 (28.2)
Hypertension	24 (57.1)	21 (53.8)	0.765
Diabetes	14 (33.3)	10 (25.6)	0.449
White blood cell, 109/L	10.0 (8.3, 15.0)	9.7 (6.8, 14.4)	0.33
Blood platelet, /L	186.0 (145.0, 249.0)	151.0 (83.0, 209.0)	0.126
APTT, seconds	38.7 (28.6, 54.4)	37.5 (27.4, 52.1)	0.606
Procalcitonin, ng/mL	2.3 (0.6, 11.2)	2.2 (0.3, 15.7)	0.712
Alanine aminotransferase, U/L	62.5 (25.5, 127.0)	63.0 (29.0, 313.0)	0.292
Total bilirubin, μmol/L	14.7 (9.1, 29.7)	14.1 (8.8, 26.7)	0.484
Serum creatinine, μmol/L	94.0 (71.5, 123.5)	95.0 (72.0, 163.0)	0.577
Left ventricular ejection fractions	31.5 (19.5, 39.0)	36.0 (29.0, 41.0)	0.097
SOFA score	10.0 (8.0, 12.0)	10.0 (9.0, 12.0)	0.181
APACHEII score	14 (12, 17)	17 (14, 19)	0.073
Vasoactive-inotropic score	19.3 ± 1.9	19.1 ± 2.0	0.782
SIRS	11 (26.2)	13 (33.3)	0.482

ECMO: Extracorporeal membrane oxygenation; HP: Hemoperfusion; APTT: Activated partial thromboplastin time; SOFA: Sequential organ failure assessment; APACHE II: Acute Physiology and Chronic Health Evaluation II; SIRS: Systemic inflammatory response syndrome.